FDA
approval
· 2016-03-03
FDA Approved: ALMOTRIPTAN — Original Application (Ajanta Pharma USA Inc.)
Summary
FDA approved Ajanta Pharma USA Inc.'s original application for Almotriptan, a generic treatment for acute migraine.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for ALMOTRIPTAN (ALMOTRIPTAN)